How many institutions held RMTI - ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share in Q2 2023?

39 institutional investors reported RMTI - ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share for Q2 2023. Use the holders table for investor-level position and value details.

ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (RMTI)

Q: What does CUSIP 774374300 represent in this 13F holders report?

CUSIP 774374300 is the security identifier for RMTI - ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 774374300

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 89,116,466
Total 13F shares: 3,083,908
Share change: +1,114,694
Total reported value: $16,820,443
Put/Call ratio: 200%
Price per share: $5.46
Number of holders: 39
Value change: +$6,248,412
Number of buys: 27
Number of sells: 12

Security key

774374300

Report period

Q2 2023

Institutions

Top holders

RMTI full security history Newer quarter: Q3 2023 Previous quarter: Q1 2023 ROCKWELL MEDICAL, INC. SEC filings ROCKWELL MEDICAL, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 774374300

Newer quarter: Q3 2023 Previous quarter: Q1 2023

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RMTI - ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Richmond Brothers, Inc.	13F	Company	0.51%	455,938	$825,224	—	31 Mar 2023	13F
ARMISTICE CAPITAL, LLC	13F	Company	0.41%	364,000	$658,840	—	31 Mar 2023	13F
PERKINS CAPITAL MANAGEMENT INC	13F	Company	0.36%	323,089	$585,000	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	0.25%	221,819	$401,492	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	0.1%	87,556	$158,477	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.09%	78,715	$142,000	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.07%	63,247	$114,477	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.07%	61,511	$111,334	—	31 Mar 2023	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.07%	59,820	$108,274	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.05%	44,360	$80,000	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.04%	33,604	$60,823	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	27,876	$50,456	—	31 Mar 2023	13F
Sigma Planning Corp	13F	Company	0.03%	25,268	$45,735	—	31 Mar 2023	13F
SkyOak Wealth, LLC	13F	Company	0.02%	19,545	$35,376	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.02%	18,188	$33,000	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.02%	14,812	$26,810	—	31 Mar 2023	13F
Verdence Capital Advisors LLC	13F	Company	0.02%	13,697	$24,792	—	31 Mar 2023	13F
SIGMA INVESTMENT COUNSELORS INC	13F	Company	0.01%	12,927	$23,398	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.01%	11,554	$20,913	—	31 Mar 2023	13F
SIMPLEX TRADING, LLC	13F	Company	0.01%	9,333	$16,000	—	31 Mar 2023	13F
UBS Group AG	13F	Company	0.01%	7,721	$13,975	—	31 Mar 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	4,837	$9,000	—	31 Mar 2023	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	2,483	$4,522	—	31 Mar 2023	13F
GROUP ONE TRADING LLC	13F	Company	0%	2,397	$4,339	—	31 Mar 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	2,140	$3,873	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	1,898	$3,435	—	31 Mar 2023	13F
BENJAMIN F. EDWARDS & COMPANY, INC.	13F	Company	0%	636	$1,000	—	31 Mar 2023	13F
Global Retirement Partners, LLC	13F	Company	0%	272	$811	—	31 Mar 2023	13F
Rise Advisors, LLC	13F	Company	0%	215	$389	—	31 Mar 2023	13F
TCI Wealth Advisors, Inc.	13F	Company	0%	21	$39	—	31 Mar 2023	13F
Advisory Services Network, LLC	13F	Company	0%	7	$13	—	31 Mar 2023	13F
John Peter Mclaughlin	3/4/5	Director	— mixed-class rows	209,831 mixed-class rows	$191,764	—	17 Jun 2021	3/4/5
Paul E. McGarry	3/4/5	SVP, Finance and CAO	— mixed-class rows	65,725 mixed-class rows	$39,921	—	17 Mar 2023	3/4/5
Marc L. Hoffman	3/4/5	Chief Medical Officer	— mixed-class rows	58,655 mixed-class rows	$35,931	—	17 Mar 2023	3/4/5
Russell H. Ellison	3/4/5	President and Chief Executive Officer, Director	— class O/S missing	200,000	—	—	03 May 2021	3/4/5
Raymond Dennis Pratt	3/4/5	Chief Development Officer	— class O/S missing	112,500	—	—	03 May 2021	3/4/5
Russell Skibsted	3/4/5	EVP, Chief Financial Officer and Chief Business Officer	— class O/S missing	80,000	—	—	09 Sep 2022	3/4/5

Institutional Holders of ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (RMTI) as of Q2 2023

As of 30 Jun 2023, ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (RMTI) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,083,908 shares. The largest 10 holders included Richmond Brothers, Inc., ARMISTICE CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, EAM Investors, LLC, JANE STREET GROUP, LLC, VANGUARD GROUP INC, Stratos Wealth Partners, LTD., BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, and TWO SIGMA INVESTMENTS, LP. This page lists 39 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.